RT Journal Article
SR Electronic
T1 Evaluation of COVID-19 RT-qPCR test in multi-sample pools
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.26.20039438
DO 10.1101/2020.03.26.20039438
A1 Yelin, Idan
A1 Aharony, Noga
A1 Tamar, Einat Shaer
A1 Argoetti, Amir
A1 Messer, Esther
A1 Berenbaum, Dina
A1 Shafran, Einat
A1 Kuzli, Areen
A1 Gandali, Nagam
A1 Hashimshony, Tamar
A1 Mandel-Gutfreund, Yael
A1 Halberthal, Michael
A1 Geffen, Yuval
A1 Szwarcwort-Cohen, Moran
A1 Kishony, Roy
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.26.20039438.abstract
AB The recent emergence of SARS-CoV-2 lead to a current pandemic of unprecedented levels. Though diagnostic tests are fundamental to the ability to detect and respond, many health systems are already experiencing shortages of reagents associated with this test. Here, testing a pooling approach for the standard RT-qPCR test, we find that a single positive sample can be detected even in pools of up to 32 samples, with an estimated false negative rate of 10%. Detection of positive samples diluted in even up to 64 samples may also be attainable, though may require additional amplification cycles. As it uses the standard protocols, reagents and equipment, this pooling method can be applied immediately in current clinical testing laboratories. We hope that such implementation of a pool test for COVID-19 would allow expanding current screening capacities thereby enabling the expansion of detection in the community, as well as in close integral groups, such as hospital departments, army units, or factory shifts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYad Hanadiv - The Rothschild Foundation in IsraelAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll raw data is available in the supplementary figures.